‹ All Posts
Vipin Dixena

19th Nov · SEBI Registration INH000014076

Why Tata Chemicals Gained 10% in November ?

Tata Chemicals ( TATACHEM ) shares continued their upward momentum as expectations of a potential Tata Sons IPO gathered pace following fresh communication from the RBI. Why Is Tata Chemicals in Focus? - Tata Chemicals holds a 2.53% stake in Tata Sons. - The value of this holding is estimated at approximately ₹30,052 crore. - On November 16, RBI advised Tata Sons to comply with all applicable regulations for upper-layer NBFCs, including the listing requirement. - Tata Sons has been classified as an upper-layer NBFC since 2022. - RBI had earlier rejected Tata Sons' application to surrender its Certificate of Registration in September 2026. - The stock has gained around 10% in November, although it remains down nearly 14% in 2026. Importantly, Tata Chemicals clarified to the exchanges that it has no knowledge of any negotiations related to a Tata Sons IPO and is therefore unable to comment on the matter. My View I believe Tata Chemicals is currently attracting attention more because of its strategic investment in Tata Sons than its standalone chemical business. A potential Tata Sons listing could create an opportunity for value unlocking, but investors should not automatically assume that the estimated value of the stake will translate into an equivalent benefit for Tata Chemicals shareholders. The timing, listing structure, valuation, applicable holding-company discount and eventual monetisation remain uncertain. I would also assess Tata Chemicals' core business performance independently rather than buying the stock purely on IPO speculation. The key distinction is simple: regulatory pressure for listing has increased, but a confirmed IPO timeline or final transaction structure is still not available. Also technically the stock is still trading below its EMA 50 in weekly chart. The stock is still making lower top lower bottom. Hence the trend is still week.

#StockInNews
277 likes·78 comments